New contract reinforces Kincell Bio’s commitment to long-term partnerships to address development and GMP manufacturing support for engineered cellular therapies. Gainesville, Florida (September 16, 2024)...
Serial entrepreneur has created, built and sold three CDMOs GAINESVILLE, Fla. – May 21, 2024 – Kincell Bio, LLC (“Kincell”), a technology-forward contract development and
Read moreKincell Bio is attending CASSS Cell & Gene Therapy Products! To connect with Bruce while we’re there, please let us know you’re coming here.
To connect with Jessica and Blaine while we’re there, please let us know you’re coming here.
To connect with Bruce while we’re there, please let us know you’re coming here.
Kincell Bio has acquired a state-of-the-art manufacturing facility in North Carolina, expanding our network to include late-phase and pivotal capabilities.
eXmoor pharma, the full-service cell and gene therapy (CGT) manufacturing partner, and Kincell Bio, a contract development and manufacturing organization (CDMO) focused on cell therapies,
Read more
